MS is classically associated with obesity and insulin resistance contributing to a series of cardiometabolic alterations that result in increased cardiovascular risk due to the fact that visceral adipose tissue produces a greater amount of proinflammatory adipokines that induce a permanent inflammatory state in this tissue by reducing its sensitivity to insulin [45,46,47]. Here, INS is linked to obesity disorder.